Follow
In Vivo
In Vivo: are those in which the effects of various biological entities are tested on whole, living organisms or cells, usually animals, including humans, and plants, as opposed to a tissue extract or dead organism.
FEB 22, 2023 | 5:30 AM
C.E. CREDITS
Ninety percent of therapeutic agents reaching clinical trial fail to reach entry to market, with safety concerns being a major cause for failures in phase I and II clinical trials. Drug-indu...
FEB 22, 2023 | 5:30 AM
C.E. CREDITS
Learning Objectives: 1. Describe and discuss some of the unique aspect of in vivo studies. 2. Identify specific study practices to ensure high quality study data and animal welfare. 3. Discu...
FEB 15, 2023 | 7:00 AM
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
NOV 09, 2022 | 8:00 AM
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
NOV 08, 2022 | 11:00 AM
Date: November 08, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CET) Developing safe and effective CAR T cell therapies is a challenging task. That’s why thinking translational earl...
NOV 01, 2022 | 8:00 AM
Date: November 01, 2022 Time: 8:00am (PDT), 1:00am (EDT), 4:00pm (CEST) This webinar will focus on sub-micron particle analysis utilizing high sensitivity violet side scatter detection. We w...
OCT 19, 2022 | 10:00 AM
Date: October 19, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) In this webinar, we will introduce the generation and applications of Biocytogen’s severely immunodeficient (B-N...
OCT 19, 2022 | 6:00 AM
At the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), emerged in China. As of September 2022, SARS-CoV...
SEP 29, 2022 | 6:00 AM
Date: September 29, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CET) The global burden of candidiasis remains relatively stable. However, the epidemiology of the last ten years shows a shi...
SEP 15, 2022 | 9:00 AM
Date: September 15, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Tyrosine kinases, a ubiquitous and diverse family of enzymes, are of considerable clinical interest because they dir...
JUN 16, 2022 | 8:00 AM
Date: June 16, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Many researchers combine electrophysiological recordings with imaging applications, where a light source with high light...
APR 27, 2022 | 9:00 AM
Date: April 27, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Abnormal accumulation of misfolded tau protein in filaments characterizes more than 20 neurodegenerative diseases—c...
APR 26, 2022 | 7:00 AM
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
APR 21, 2022 | 8:00 AM
Date: April 21, 2022 Time: 8:00am (PDT), 11:00am (EDT), 6:00pm (CEST) Due to the low frequency of B cells in human peripheral blood, it can be difficult to obtain sufficient numbers of B cel...
APR 06, 2022 | 10:30 AM
Learning Objectives: 1. Explain what is gene therapy is. 2. Explain what steps are involved for getting a gene therapy product to the clinic. 3. Discuss development and manufacturing process...
APR 06, 2022 | 5:30 AM
In the last decades, the upstream processing in biopharma industry has been revolutionized regarding the production of bioactive materials such as monoclonal antibodies, proteins and biother...
MAR 16, 2022 | 9:00 AM
Date: March 16, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEDT) With a renewed and growing interest in therapeutic oligonucleotides (oligos) across the pharmaceutical industry, the req...
MAR 10, 2022 | 11:55 PM
Neuroscience is experiencing an exciting era of integrating novel materials and tools to record neural activity made possible through significant advances in materials science, electrical en...
MAR 10, 2022 | 11:55 PM
Alzheimer’s and Parkinson’s diseases (AD, PD) are the two most common neurodegenerative disorders. Despite their debilitating effects and increasing prevalence in our society, no...
